Table 2 Prevalence [95% CI] of schizophrenia in MarketScan and Medicaid (2019).
Population | Total | Male | Female | ≤35 years | |
|---|---|---|---|---|---|
Medicaid Total | Total | 4,414,153 | 1,955,914 | 2,457,890 | 1,653,261 |
Schizophrenia | 94,153 | 54,829 | 39,324 | 20,627 | |
Prevalence [95%CI] | 2.13% [2.12,2.15] | 2.80% [2.78,2.83] | 1.60% [1.58,1.62] | 1.25% [1.23,1.26] | |
Medicaid 10 year Continuously Insured | Total | 785,088 | 305,781 | 479,307 | 302,619 |
Schizophrenia | 45,068 | 24,130 | 20,938 | 4,687 | |
Prevalence [95%CI] | 5.74% [5.69,5.79] | 7.89% [7.80,7.99] | 4.37% [4.31,4.43] | 1.549% [1.505,1.593] | |
MarketScan Total | Total | 16,365,997 | 7,505,072 | 8,860,925 | 5,662,318 |
Schizophrenia | 21,963 | 10,169 | 11,794 | 8,183 | |
Prevalence [95%CI] | 0.134% [0.132,0.135] | 0.135% [0.133,0.138] | 0.133% [0.131,0.136] | 0.145% [0.141,0.148] | |
MarketScan 10 year Continuously Insured | Total | 951,173 | 361,235 | 589,938 | 220,307 |
Schizophrenia | 1,519 | 664 | 855 | 457 | |
Prevalence [95%CI] | 0.159% [0.152,0.168] | 0.183% [0.170,0.198] | 0.145% [0.136,0.155] | 0.207% [0.189,0.227] |
